A Guide to State Opioid Prescribing Policies

 

State Opioid Prescribing Policy: Illinois

 

David Brushwood, RPh, JD
Author Information

Pain Policy and Regulation: Illinois

Illinois Statutes

  • 720 ILCS 570/309: Under Illinois law there are additional requirements for the oral prescribing of a C-II medication in an emergency situation. These are:
    • The failure to issue the prescription might result in loss of life or intense suffering.
    • The prescription must include a statement from the prescriber concerning the accident or calamity or circumstances constituting the emergency.
    • The prescription must state the cause (purpose) for which the oral prescription was issued.
  • 720 ILCS 570/312: A prescription for a C-II controlled substance may not be filled more than 7 days after the date of issuance.
  • 720 ILCS 570/316: In Illinois there is a C-II controlled substance prescription monitoring program. The following information must be transmitted to a central repository by the dispenser:
    • The recipient's name
    • The recipient's address
    • The national drug code or the C-II dispensed
    • The date the drug is dispensed
    • The quantity of the drug dispensed
    • The dispenser's Drug Enforcement Agency registration number
    • The prescriber's Drug Enforcement Agency registration number

Illinois Administrative Regulations

  • 68 Ill.Admin.Code 1305.40: A collaborating physician who delegates limited prescriptive authority to an advanced registered nurse practitioner may not delegate authority to prescribe C-II controlled substances.
  • 77 Ill.Admin.Code 3100.380: A controlled substance prescription must be issued for a legitimate medical purpose and in the usual course of professional practice. The responsibility for the proper prescribing and dispensing of controlled substances rests with the prescribing practitioner, but a corresponding responsibility rests with the pharmacist who fills the prescription.

Author Information

David B. Brushwood, RPh, JD, Professor, University of Florida College of Pharmacy, Gainesville

Disclosure: David B. Brushwood, RPh, JD, has disclosed no relevant financial relationships.

Medscape Neurology & Neurosurgery.  2008; ©2008 Medscape

 

Latest News

 
 

Ask The Experts

 
 
Legal Disclaimer:  The purpose of these summaries is to inform and educate clinicians on the various legal/regulatory materials that govern the use of controlled substances to treat pain. The information contained within these summaries is not intended to serve as specific legal advice, and you should review the source material and consult your local attorney and/or state licensing board to determine the relevance to your practice.
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC. This website also contains material copyrighted by 3rd parties.